Acquired Company

miRagen Therapeutics completed the acquisition of Viridian Therapeutics, Inc. on October 28, 2020.

Viridian Therapeutics, Inc. is a pioneering biopharmaceutical company based in Boulder, Colorado, focused on developing innovative therapies for rare and autoimmune disorders. The company is committed to addressing significant unmet medical needs through its robust pipeline of drug candidates, which are grounded in cutting-edge research and development. With a strategic emphasis on enhancing patient outcomes, Viridian is positioned to drive transformative advancements in the treatment of severe diseases, establishing its presence as a key contributor within the biopharmaceutical sector. Show more

Location: 221 CRESCENT STREET, WALTHAM, MA, UNITED STATES, 02453, Waltham, MA, 02453, USA | Website: https://www.viridiantherapeutics.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

3.15B

52 Wk Range

$9.90 - $34.29

Previous Close

$33.00

Open

$32.72

Volume

1,390,200

Day Range

$32.22 - $34.18

Enterprise Value

2.924B

Cash

169.6M

Avg Qtr Burn

-84.61M

Insider Ownership

0.14%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Veligrotug (formerly VRDN-001) Details Thyroid Eye Disease	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VRDN-003 Details Thyroid Eye Disease	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Veligrotug (formerly VRDN-001) Details Thyroid Eye Disease	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VRDN-006 Details No known indication	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VRDN-008 Details No known indication	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.